#ayurvedic

Recure Healthcarerecurehealthcare
2025-03-20

Dr Divyani Bhagat Recommends Cholecon Plus for Heart Health!

A respected Ayurvedic expert and distinguished doctor highly recommends Cholecon Plus as the premier choice for nurturing a strong heart. Unlock the benefits of Ayurvedic wisdom and safeguard your heart health with Cholecon Plus today! šŸ’Š

Buy Now - recurehealthcare.com/product/c

Subir Pal vedic astrologersubirpal
2025-03-15
Colour Spa & Hammam | Kolkatacolourspaandhammam
2025-02-16

Find Your Serenity at Colour Spa & Hammam!

Indulge in the finest spa and massage treatments in Kolkata! From massage to Deep Tissue & Aromatherapy, we offer pure relaxation.

šŸ“ Chinar Park, near Kolkata Airport
šŸ“ž 8100331151
🌐 zurl.co/hqpOw

Colour Spa And Hammam – Best Spa in KolkataColour Spa And Hammam – Best Spa in KolkataColour Spa And Hammam – Best Spa in Kolkata
2025-02-10

There was some US football game yesterday, so today is #NationalPoopDay; learn about the #Ayurvedic elixer made from feces and urine toilet-guru.com/blog/10.html?s

Life Avedahealthlifeaveda
2025-01-24

Ayurvedic Medicine for Prostate

lifeavedahealth.com/products/p

Discover natural relief with Ayurvedic medicine for prostate health. Harness the power of herbs like Gokshura, Shilajit, and Varuna to support prostate wellness, manage urinary issues, and promote overall vitality. Safe, effective, and holistic care for men’s health!

Medicine for Prostate#Ayurvedic medicine for Enlarged Prostate

Best ayurvedic medicine for prostate
2025-01-08

A sales job: What Astrotalk’s 41,000 astrologers didn’t see in their future

Asked a bunch of career-related queries, the astrologer doesn’t answer but instead asks follow-up questions. Finally, just as the two-minute timer runs out, she says, ā€œYour kundli (birth chart) is very good. Please recharge once, so I can help you.ā€

A recharge of ₹50 is duly made to buy an additional six minutes or so. And with that, the astrologer has turned this writer into a paying customer. This conversion is how the astrologer and the platform make money—the longer the conversation, the more the customer has to recharge, and the more they earn.

Astrologers have been an integral part of life in India since vedic times and are revered members of the community. Their presence looms large in many Indian households and they play an outsized role in influencing the decisions people make, from whom they marry and the auspicious date to begin a new job, to changing homes and naming newborns.

Astrologers base their advice on planetary positions and movements and perform pujas to appease various deities. They also recommend remedies, such as wearing gemstones to enhance positive influences or neutralize negative ones. Beyond predictions, they often act as counsellors, fostering hope when people approach them in uncertain times.

Noida-based Astrotalk has hit a goldmine by adapting this ancient belief system to the digital age, monetizing the influential role astrologers play in people’s lives in a very profitable way. The company claims to have over 41,000 astrologers on its platform, consulting with more than 4,50,000 daily users and over 2.5 million monthly users.

Astrotalk has quietly become a standout success in the tech landscape, generating substantial profits at a time when many startups are struggling with growth and funding. The company’s revenue doubled to ₹651 crore in FY24 from ₹283 crore in FY23. Profit jumped more than 12-fold over the same period, from ₹8 crore in FY23 to ₹100 crore in FY24, according to data from Tofler.

Needless to say, the seven-year-old company has quickly become the leader in the astrology space with its army of astrologers and massive customer base. Rivals Astrosage and Astroyogi are much smaller in comparison.

The company has raised a total of $30 million so far, from backers such as Left Lane Capital and Elev8 Venture Partners and was valued at $300 million after its last fundraise in June 2024. Astrotalk has used that funding to spend freely in an aggressive effort to widen its customer base, with ads around marriage, love, life and jobs. It has more than doubled its expense on marketing, spending ₹163 crore in FY24 against ₹75 crore in FY23.

However, while its partnership with astrologers has been mutually beneficial so far, the relationship has begun to fray. The astrologers, who may not have foreseen recent events, are a disgruntled lot, and some have parted ways with the platform.

Unforeseen turn of events

Mint’s conversations with about 15 astrologers, five of whom have left the platform, revealed that in the last few months, Astrotalk has been pushing them to keep customers engaged longer, linking their incomes to their ability to have extended conversations.

ā€œIt’s like a call centre now and not so much an astrology platform,ā€ said one astrologer, noting that the main focus has been on making the customer stay longer, improving repeat business and increasing revenue.


View Full Image

A screen grab of Astrotalk’s website.  

The company did not respond to Mint’s requests for an interaction or respond to a detailed questionnaire.

Originally, the company and the astrologer would have a 50-50 revenue split for each chat or call, an astrologer told Mint. If a customer recharged ₹100, the payment charges would first be deducted, and the remainder would be split equally between the company and the astrologer, with tax deducted from the latter’s payout.

But many astrologers alleged that Astrotalk has been recouping its heavy marketing spend by taking a cut from their pockets. ā€œThey initially said that the company’s share would increase to 60% because it would spend 10% on marketing. When it launched other applications, the company said it would reduce the astrologer’s share from 40% to 30%, increasing the company’s share to 70%, because it would be spending 20% on marketing,ā€ said one soothsayer.

Today, astrologers are asked to speak with a customer for more than 30 minutes to avail the original 50-50 payment split—the company takes 70% of the share for the first 30 minutes.

ā€œOften we have to just stretch the conversation to reach the 30-minute point,ā€ said one astrologer, noting that the profiles of those who have converted fewer customers do not appear before new users. Another said he recently received a call from the company offering training on converting users into loyal customers.

 

Often we have to just stretch the conversation to reach the 30-minute point.
— An astrologer

ā€œEven if you want to, in astrology, you can’t consult somebody for over half an hour. As he is paying by the minute, he also asks pointed questions and expects straightforward answers,ā€ said a fourth astrologer, who left the platform a few months back.

ā€œIf you keep on lying and go roundabout with your answers, only then can you convert them into loyal customers,ā€ said another astrologer, adding that customer support told him to suggest remedies to customers and ask them to come back and talk about the outcome. Mint couldn’t verify this as the source did not have a screenshot of the chat.

All of the astrologers Mint spoke with requested anonymity as they foresee a pushback by the company otherwise.

ā€˜Suggest remedies, earn more’

Astrotalk was launched by Puneet Gupta, a graduate from Punjab Engineering college, Chandigarh. Earlier, he had quit his job as a developer in financial services company Nomura Services in Mumbai to dabble in various businesses, including an Ayurvedic venture with his grandfather, which did not work out.

Early in 2015, Gupta started an IT service company named CodeYeti and ran it for a couple of years before pivoting the entire business to a product named Astrotalk in October 2017.


View Full Image

A company handout of founder Puneet Gupta (right) and co-founder Anmol Jain.

The app began as an intermediary, connecting users with astrologers for personalized consultations. Over the years, it has expanded its offerings to include a diverse range of services, such as tarot card readings, numerology, and Vedic astrology.

A few months ago, the company started an ecommerce service called Astromall to sell all kinds of remedies to users. Those remedies are proving to be another bone of contention with the astrologers.

These remedies include bracelets and pendants, e-pooja, reiki healing, gemstones, spells, evil eye removal, and rudrakshas. Their cost ranges from ₹250 to ₹6,200, with astrologers getting a commission of 20-50%.

As the ticket size of these products is bigger than consultations, leading to higher margins, the company has been pushing its astrologers to sell them. ā€œThis is a wonderful opportunity to boost your earnings while continuing to help users find the right gemstones for their needs,ā€ read one such message to them, seen by Mint. But the move has not gone down well with the astrologers.

Three astrologers said that they had received calls from company executives either asking them to ā€œsuggest remediesā€ or flagging them for not suggesting remedies for many days.

ā€œThey say, ā€˜You haven’t suggested a remedy in some time. You should do that and you will get a commission.’ If I have seen your kundli and I don’t see a need, why would I suggest a remedy or a gemstone,ā€ said one astrologer.

ā€œIt’s not right how they are doing things. Astrology is seva (service) but they have made it all about money,ā€ another added.

There’s a ranking board, visible to all astrologers, where the company shows the earnings of astrologers on Astrotalk consultations as well as Astromall. ā€œIf your income is less, your rating goes down. It gets very difficult for an astrologer to work honestly at this point,ā€ said one of them.

Wildly wrong

While the astrologers are unhappy with Astrotalk’s operational calls, they themselves have come in for much flak from customers. Priyanshu Manas, a New Delhi-based marketing professional, tried Astrotalk when he came across an ad promoting a two-minute free chat with astrologers. Manas said the astrologer he spoke to was wildly off the mark in her responses. He, however, got clarity on one question that was burning in his mind, and it had nothing to do with the future; Manas wanted to ascertain whether an astrologer could actually determine current realities based on his birth chart. ā€œI asked whether I was single or in a relationship. She said I was committed—I’m actually single. When I asked if I was in debt, she said I was debt-free—I have significant debt. When I asked about the good and bad aspects of my life, she offered the typical response: ā€˜Your future is very bright.ā€™ā€

Manas isn’t the only one. In a LinkedIn post, Rupesh Mehta, founder of Salad Time, a Vadodara-based food company, said he had used Astrotalk’s service five times over the last two years. While he was convinced that astrologers simply tell people what they want to hear and dish out generic advice and feelgood statements, he realized that there was a conscious effort by Astrotalk’s astrologers to sell rituals or services. ā€œTo test consistency, I asked the same question to two different astrologers on the same day but framed it slightly differently. Surprisingly, I got completely different answers,ā€ Mehta said.


View Full Image

A screenshot of Rupesh Mehta’s post.

On Google’s Play store, one crestfallen user, who was on Astrotalk for more than a year, and had spent over ₹5,000, expressed her angst in a scathing review. ā€œNot even a single prediction came true for me.… I have contacted almost 7-8 astrologers on this app, but nothing works, not even the remedies they provided. I … wasted my time, my hope and my money,ā€ she wrote.


View Full Image

A user’s review on Google Play.

Others have expressed suspicion that the answers to their queries were from bots, with one user saying he got the same responses verbatim from five astrologers.

Not everyone is dissatisfied, though; the app has also received a significant number of positive reviews on the Play store. ā€œTheir ability to understand my concerns and offer practical solutions was remarkable. The session left me feeling rejuvenated and optimistic about the future,ā€ one user posted in his review.

Other user reviews have criticized the free chats advertised aggressively by Astrotalk, with some suggesting that the feature is nothing more than bait to lure people in and bilk them.

More free chats

While customers are upset because they do not get any answers during the free chats, astrologers aren’t pleased with the feature either. ā€œWe had to do about five free sessions post which we would get paid customers. The free chats have now increased to about 10 every day,ā€ an astrologer told Mint.

Almost all the astrologers Mint spoke with said that the free chats, without which they do not get paid chats, have increased. Astrotalk has cut the time for a free chat from five minutes to two minutes.

One astrologer explained that it is hard to convert customers because it’s difficult to answer any questions in two minutes. ā€œThey have heavy traffic and an army of astrologers and quality has taken a backseat,ā€ this person said.


View Full Image

Screenshot of an ad run by Astrotalk.

Another soothsayer concurred, saying that it is practically impossible to analyse or suggest anything within two minutes. ā€œAs an astrologer, it feels very wrong. The customer will bombard you with 10 questions. When they don’t get answers, they feel ripped off and do not come back,ā€ the person added.

The company has also introduced promotional offers for newer astrologers. ā€œEarlier, they used to give ₹5 per minute for free chats. Now, they are giving ₹1 per minute,ā€ said one astrologer.

Disheartened by all these changes, one astrologer quit the platform. ā€œAs an astrologer, I need respect and I need money. I can’t sit like it’s a photocopy shop speaking to customers for a few minutes and earning ₹10 for it,ā€ he told Mint.

Is it just entertainment?

Interestingly, Astrotalk has a disclaimer on its website that says its services are for entertainment purposes only and that it is not responsible for predictions or advice.


View Full Image

A screenshot of Astrotalk’s disclaimer on its website.

There are no regulations in India governing astrology platforms. However, these startups have to generally comply with the IT Act and IT Rules as well as Consumer Protection (E-Commerce) Rules, 2020, say legal experts. Astrotalk may be claiming that its services are for entertainment purposes only, but such disclaimers do not exempt a company from its legal obligations, they note.

ā€œWhile the law has not specifically defined such activities as ā€˜entertainment’, astrology tech startups are simply trying to avoid any liability by claiming as such,ā€ Salman Warris, a technology lawyer and founder of law firm TechLegis, told Mint. ā€œBut if a case goes to court, it will most probably be held otherwise. The court’s recognition of astrology as a science suggests that such platforms are accountable for the accuracy and reliability of the services they provide.ā€

Meanwhile, entertainment providers or otherwise observers expect Astrotalk to keep growing. ā€œUrbanization, digital maturity of internet users and democratization of access to best-in-class astrologers are all tailwinds for the market growth in the space,ā€ said Mukesh Kumar, Associate Partner at Redseer.

In a recent post on LinkedIn, founder Gupta said people would receive ₹100 in exchange for following Astrotalk’s official account on X, formerly Twitter, and sharing their number with the company to get the payout. Astrotalk has built itself up on the back of such marketing tactics. But, it may need to take a hard look at what the future holds if it pursues growth to the detriment of customers and astrologers, the two pillars supporting its lucrative business model. Gupta doesn’t need an astrologer to see that.

Source link

Share this:

#astrologers #astrology #Astromall #Astrosage #Astrotalk #Astroyogi #Ayurvedic #CodeYeti #consultations #digitalAge #Funding #GooglePlay #marketingSpending #paymentSplit #PuneetGupta #remedies #revenueSplit #review #taxDeducted #Urbanization

2024-12-24

Whether you aim to alleviate stress, detoxify, or enhance vitality, the resort’s therapies—rooted in ancient #Ayurvedic wisdom—are tailored to your specific needs. Indulge in relaxing massages, herbal treatments, and time-tested remedies designed to restore balance and vitality.

South FirstTheSouthFirst
2024-11-26

Can food cure Stage-IV cancer? claims his wife’s diet made her cancer-free in 40 days.

Oncologists, however, present a different perspective.
Read more: thesouthfirst.com/health/navjo

JAI RISHI AYURVEDAjairishiayurveda
2024-09-24

Experience the efficacy of holistic healing with Jairishi Ayurveda's Ayurvedic Medicine Services! 🌿✨ Accept age-old cures that aim to bring your body, mind, and soul back into harmony. From tailored wellness plans to natural medicines, we offer a full approach to health that encourages vitality and inner harmony. Discover the wisdom of Ayurveda right now! šŸŒ±šŸ§˜ā€ā™‚ļø "
.
Follow @jairishiayurveda
.

Steve Dustcircle 🌹dustcircle@masto.ai
2024-09-18
South FirstTheSouthFirst
2024-05-04

, -based institution to jointly conduct clinical trials of medicines

Patanajali Yogpeeth general secretary Acharya Balkrishna said the MoU will prove to be a milestone in the history of Ayurveda.
thesouthfirst.com/tamilnadu/pa

2024-04-11

the reason why i get more emotional now is because my father is getting older and the untested nature of #ayurvedic concoctions scare me far more than his individual health issues. i try my best to get him off any stupid shit and it is half a battle each time.

faith is stronger than reason

curlyteacurlytea
2024-03-13

Promote healthy hair growth and scalp care with amla oil, an ayurvedic favorite! I love this oil. Add it to another hair-loving carrier oil to make it last longer.

2024-02-12

There was some US football game yesterday, so today is #NationalPoopDay; learn about the #Ayurvedic elixer made from feces and urine toilet-guru.com/blog/10.html?s

  1. BAKER JB, Ghatak A, Cullen MR, Horwitz RI, et al.
    Development of a Novel Clinical Risk Score for COVID-19 Infections.
    Am J Med. 2023;136:1169-1178.
    PubMed: https://www.amedeo.com/p2.php?id=37704073&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37704073
  2. TENFORDE MW, Dawood FS, Ellington SR, Grohskopf LA, et al.
    Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine
    Effectiveness to Acceptance.
    Ann Intern Med. 2023 Nov 28. doi: 10.7326/M23-2802.
    PubMed: https://www.amedeo.com/p2.php?id=38011706&s=flu&pm=2
     
    Share: https://m.amedeo.com/38011706
  3. HWANG CS, Kesselheim AS, Sarpatwari A, Huybrechts KF, et al.
    Changes in Induced Medical and Procedural Abortion Rates in a Commercially
    Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.
    Ann Intern Med. 2023 Oct 24. doi: 10.7326/M23-1609.
    PubMed: https://www.amedeo.com/p2.php?id=37871317&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37871317
  4. JAMSHIDINIA N, Saadatpour F, Arefian E, Mohammadipanah F, et al.
    Augmented antiviral activity of chlorhexidine gluconate on herpes simplex virus
    type 1, H1N1 influenza A virus, and adenovirus in combination with salicylic
    acid.
    Arch Virol. 2023;168:302.
    PubMed: https://www.amedeo.com/p2.php?id=38036721&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38036721
  5. LOOI MK.
    ā€œWe weren’t that great at treating flu-it should not be our model for covidā€:
    America’s covid-19 tsar speaks.
    BMJ. 2023;383:p2743.
    PubMed: https://www.amedeo.com/p2.php?id=38030216&s=flu&pm=2
     
    Share: https://m.amedeo.com/38030216
  6. O’CALLAGHAN C, Cloutman-Green E, Brierley J.
    Pandemic preparedness: is the UK ready for a pandemic that affects children?
    BMJ. 2023;383:2804.
    PubMed: https://www.amedeo.com/p2.php?id=38016735&s=flu&pm=2
     
    Share: https://m.amedeo.com/38016735
  7. MAHASE E.
    Swine flu: UK reports its first human case of A(H1N2)v strain.
    BMJ. 2023;383:2819.
    PubMed: https://www.amedeo.com/p2.php?id=38016716&s=flu&pm=2
     
    Share: https://m.amedeo.com/38016716
  8. DYER O.
    Pfizer sues Poland over unclaimed covid vaccines.
    BMJ. 2023;383:2810.
    PubMed: https://www.amedeo.com/p2.php?id=38016715&s=flu&pm=2
     
    Share: https://m.amedeo.com/38016715
  9. LOOI MK.
    China: Rising cases of respiratory disease and pneumonia spark WHO concern.
    BMJ. 2023;383:2770.
    PubMed: https://www.amedeo.com/p2.php?id=37996101&s=flu&pm=2
     
    Share: https://m.amedeo.com/37996101
  10. KASEYA J, Machingaidze S.
    How African countries can prepare for the next pandemic.
    BMJ. 2023;383:2762.
    PubMed: https://www.amedeo.com/p2.php?id=37996100&s=flu&pm=2
     
    Share: https://m.amedeo.com/37996100
  11. RIMMER A.
    Clinicians with long covid must get financial support, say unions.
    BMJ. 2023;383:2723.
    PubMed: https://www.amedeo.com/p2.php?id=37977571&s=flu&pm=2
     
    Share: https://m.amedeo.com/37977571
  12. ZHANG L, Zhang X, Deng X, Wang P, et al.
    Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal
    transition in COVID-19 lung fibrosis.
    Biochem Biophys Res Commun. 2023;686:149118.
    PubMed: https://www.amedeo.com/p2.php?id=37931361&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37931361
  13. DE GERMAY S, Singier A, Salvo F, Pariente A, et al.
    Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in
    France.
    Drug Saf. 2023;46:1381-1389.
    PubMed: https://www.amedeo.com/p2.php?id=37926785&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37926785
  14. ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al.
    Association of recent respiratory illness and influenza with acute myocardial
    infarction among the Bangladeshi population – a case-control study.
    Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863.
    PubMed: https://www.amedeo.com/p2.php?id=38031480&s=flu&pm=2
     
    Share: https://m.amedeo.com/38031480
  15. ALICANDRO G, La Vecchia C, Islam N, Pizzato M, et al.
    A comprehensive analysis of all-cause and cause-specific excess deaths in 30
    countries during 2020.
    Eur J Epidemiol. 2023;38:1153-1164.
    PubMed: https://www.amedeo.com/p2.php?id=37684387&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37684387
  16. SASIDHARAN A, Selvarangan R, Konrad K, Faron ML, et al.
    Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV
    assay in nasopharyngeal swab specimens from symptomatic individuals.
    J Clin Microbiol. 2023;61:e0082723.
    PubMed: https://www.amedeo.com/p2.php?id=37902331&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37902331
  17. JIN Z, Wu J, Wang Y, Huang T, et al.
    Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized,
    double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical
    trial in healthy Chinese adults.
    J Infect. 2023 Oct 26:S0163-4453(23)00543-1. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37898410&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37898410
  18. PAN D, Hui DSC, Tang JW.
    Defining infection transmission pathways for future pandemic preparedness – An
    urgent public health research priority.
    J Infect. 2023;87:595-597.
    PubMed: https://www.amedeo.com/p2.php?id=37865295&s=flu&pm=2
     
    Share: https://m.amedeo.com/37865295
  19. HA L, Levian C, Greene N, Goldfarb I, et al.
    Association between acceptance of routine pregnancy vaccinations and COVID-19
    vaccine uptake in pregnant patients.
    J Infect. 2023 Oct 19:S0163-4453(23)00541-8. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37865294&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37865294
  20. MARJANEH MM, Challenger JD, Salas A, Gomez-Carballa A, et al.
    Analysis of blood and nasal epithelial transcriptomes to identify mechanisms
    associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
    J Infect. 2023 Oct 18:S0163-4453(23)00540-6. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37863321&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37863321
  21. FENWICK C, Turelli P, Duhoo Y, Lau K, et al.
    Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and
    provides full protection in monkeys.
    J Infect. 2023 Oct 16:S0163-4453(23)00539-X. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37852477&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37852477
  22. BEARD KR, Borca F, Phan H, Brown E, et al.
    Routine, molecular point-of-care testing for SARS-CoV-2 and other respiratory
    viruses within an acute oncology service improves patient care.
    J Infect. 2023 Oct 4:S0163-4453(23)00514-5. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37802471&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37802471
  23. TIAN S, Liu T, Zhao XJ, Liu XL, et al.
    Neutralization against emerging Omicron subvariants after SARS-CoV-2 reinfection.
    J Infect. 2023 Oct 4:S0163-4453(23)00515-7. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37802470&s=flu&pm=2
     
    Share: https://m.amedeo.com/37802470
  24. VELLAS C, Latour J, Tremeaux P, Ranger N, et al.
    Molecular Evolution of Omicron Variant in Immunocompromised Individuals with
    Chronic SARS-CoV-2 Infection.
    J Infect. 2023 Sep 30:S0163-4453(23)00513-3. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37783375&s=flu&pm=2
     
    Share: https://m.amedeo.com/37783375
  25. ANTONELLI M, Penfold RS, Canas LDS, Sudre C, et al.
    SARS-CoV-2 infection following booster vaccination: illness and symptom profile
    in a prospective, observational community-based case-control study.
    J Infect. 2023 Sep 28:S0163-4453(23)00461-9. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37777159&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37777159
  26. GAO Y, Zhang Y, Mou K, Man S, et al.
    Alterations in the outer retina and choroid in patients after COVID-19 infection.
    J Infect. 2023 Sep 27:S0163-4453(23)00512-1. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37774846&s=flu&pm=2
     
    Share: https://m.amedeo.com/37774846
  27. YAMAMOTO S, Mizoue T, Konishi M, Oshiro Y, et al.
    Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2
    reinfection.
    J Infect. 2023 Sep 26:S0163-4453(23)00511-X. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37769951&s=flu&pm=2
     
    Share: https://m.amedeo.com/37769951
  28. SNOW TAC, Arulkumaran N, Singer M, Choi SH, et al.
    Effect of dexamethasone dose on outcomes in acute COVID-19 disease: a systematic
    review and meta-analysis.
    J Infect. 2023 Sep 25:S0163-4453(23)00510-8. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37757919&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37757919
  29. MATSUO OM, Lindoso L, Sousa Marques HH, Polanczyk GV, et al.
    Mental health among children and adolescents after SARS-CoV-2 infection: a
    prospective study in a tertiary university hospital.
    J Infect. 2023 Sep 20:S0163-4453(23)00507-8. doi: 10.1016/j.jinf.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37739272&s=flu&pm=2
     
    Share: https://m.amedeo.com/37739272
  30. FELL DB, Russell M, Fung SG, Swayze S, et al.
    Effectiveness of maternal influenza vaccination during pregnancy against
    laboratory-confirmed seasonal influenza among infants under 6 months of age in
    Ontario, Canada.
    J Infect Dis. 2023 Nov 29:jiad539. doi: 10.1093.
    PubMed: https://www.amedeo.com/p2.php?id=38029414&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38029414
  31. LEE K, Williams KV, Englund JA, Sullivan SG, et al.
    The potential benefits of delaying seasonal influenza vaccine selections for the
    Northern Hemisphere: a retrospective modeling study in the United States.
    J Infect Dis. 2023 Nov 29:jiad541. doi: 10.1093.
    PubMed: https://www.amedeo.com/p2.php?id=38019883&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38019883
  32. FRANKLIN A, John TM, Khawaja F, Jiang Y, et al.
    Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in
    Patients With Cancer.
    J Infect Dis. 2023;228:1549-1558.
    PubMed: https://www.amedeo.com/p2.php?id=37983000&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37983000
  33. ERNST T, Ryan MC, Liang HJ, Wang JP, et al.
    Neuronal and Glial Metabolite Abnormalities in Participants With Persistent
    Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance
    Spectroscopy Study.
    J Infect Dis. 2023;228:1559-1570.
    PubMed: https://www.amedeo.com/p2.php?id=37540098&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37540098
  34. BRAUNSTEIN SL, Wahnich A, Lazar R.
    COVID-19 outcomes among people with HIV and COVID-19 in New York City.
    J Infect Dis. 2023 Aug 3:jiad311. doi: 10.1093.
    PubMed: https://www.amedeo.com/p2.php?id=37534822&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37534822
  35. ONWUCHEKWA C, Atwell J, Moreo LM, Menon S, et al.
    Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A
    Systematic Review and Meta-analysis.
    J Infect Dis. 2023;228:1516-1527.
    PubMed: https://www.amedeo.com/p2.php?id=37285396&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37285396
  36. OSEI-YEBOAH R, Spreeuwenberg P, Del Riccio M, Fischer TK, et al.
    Estimation of the Number of Respiratory Syncytial Virus-Associated
    Hospitalizations in Adults in the European Union.
    J Infect Dis. 2023;228:1539-1548.
    PubMed: https://www.amedeo.com/p2.php?id=37246742&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37246742
  37. DEL RICCIO M, Spreeuwenberg P, Osei-Yeboah R, Johannesen CK, et al.
    Burden of Respiratory Syncytial Virus in the European Union: estimation of
    RSV-associated hospitalizations in children under 5 years.
    J Infect Dis. 2023;228:1528-1538.
    PubMed: https://www.amedeo.com/p2.php?id=37246724&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37246724
  38. ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al.
    SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host
    adaption.
    J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
    PubMed: https://www.amedeo.com/p2.php?id=37929963&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37929963
  39. PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al.
    Identification of host dependency factors involved in SARS-CoV-2 replication
    organelle formation through proteomics and ultrastructural analysis.
    J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
    PubMed: https://www.amedeo.com/p2.php?id=37905840&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37905840
  40. BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al.
    Vaccine-induced antibody Fc-effector functions in humans immunized with a
    combination Ad26.RSV.preF/RSV preF protein vaccine.
    J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
    PubMed: https://www.amedeo.com/p2.php?id=37902399&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37902399
  41. UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al.
    Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle
    restores cell signaling network.
    J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
    PubMed: https://www.amedeo.com/p2.php?id=37861336&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37861336
  42. KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al.
    Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its
    conformation, fusogenicity, and neutralization sensitivity.
    J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
    PubMed: https://www.amedeo.com/p2.php?id=37861334&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37861334
  43. YE G, Pan R, Bu F, Zheng J, et al.
    Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum
    therapeutic nanobody candidates against COVID-19.
    J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
    PubMed: https://www.amedeo.com/p2.php?id=37855638&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37855638
  44. SUN H, Wang Y, Chen X, Jiang Y, et al.
    Structural basis for broad neutralization of human antibody against Omicron
    sublineages and evasion by XBB variant.
    J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
    PubMed: https://www.amedeo.com/p2.php?id=37855619&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37855619
  45. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al.
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy
    for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    PubMed: https://www.amedeo.com/p2.php?id=37846985&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37846985
  46. WU Y, Shi J, He X, Lu J, et al.
    Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its
    variants.
    J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
    PubMed: https://www.amedeo.com/p2.php?id=37843372&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37843372
  47. BERGMAN C.
    Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023;330:2021-2022.
    PubMed: https://www.amedeo.com/p2.php?id=38015226&s=flu&pm=2
     
    Share: https://m.amedeo.com/38015226
  48. MCGARRY BE, Sommers BD, Barnett ML.
    Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
    JAMA. 2023;330:2022.
    PubMed: https://www.amedeo.com/p2.php?id=38015222&s=flu&pm=2
     
    Share: https://m.amedeo.com/38015222
  49. HARRIS E.
    FDA Will Evaluate First Self-Administered FluMist Vaccine.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.
    PubMed: https://www.amedeo.com/p2.php?id=37938864&s=flu&pm=2
     
    Share: https://m.amedeo.com/37938864
  50. HARRIS E.
    Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
    PubMed: https://www.amedeo.com/p2.php?id=37938859&s=flu&pm=2
     
    Share: https://m.amedeo.com/37938859
  51. HARRIS E.
    HRSA Study: US Abortions Decreased 14% During COVID-19.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
    PubMed: https://www.amedeo.com/p2.php?id=37910083&s=flu&pm=2
     
    Share: https://m.amedeo.com/37910083
  52. ZIAUDDEEN N, Pantelic M, O’Hara ME, Hastie C, et al.
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    PubMed: https://www.amedeo.com/p2.php?id=37997145&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997145
  53. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al.
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration
    between public health teams in local authorities, NHS hospital trusts, NHS
    commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    PubMed: https://www.amedeo.com/p2.php?id=37997141&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997141
  54. Nowcasting waiting lists for elective procedures and surgery in England: a
    modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    PubMed: https://www.amedeo.com/p2.php?id=37997119&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997119
  55. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB.
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories
    of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    PubMed: https://www.amedeo.com/p2.php?id=37997116&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997116
  56. MARTIN A, Jamieson S.
    Exploring the experiences of junior doctors who were shielding during the
    COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    PubMed: https://www.amedeo.com/p2.php?id=37997112&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997112
  57. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al.
    Effect of trade unions on the mental health of UK workers before and during the
    COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    PubMed: https://www.amedeo.com/p2.php?id=37997106&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997106
  58. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al.
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in
    Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    PubMed: https://www.amedeo.com/p2.php?id=37997105&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997105
  59. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al.
    Changes in food and drink purchasing behaviour in England during the first 3
    months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    PubMed: https://www.amedeo.com/p2.php?id=37997104&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997104
  60. HAZIR SG, Ryan C, Moore A, Lewis C, et al.
    The role of the multiple Index of deprivation in predicting mental health
    outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    PubMed: https://www.amedeo.com/p2.php?id=37997089&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997089
  61. DU Z, Wang L, Bai Y, Pei Y, et al.
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the
    COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    PubMed: https://www.amedeo.com/p2.php?id=37997080&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997080
  62. ARNOTT J, Troya MI, Joyce M, Khashan A, et al.
    Untangling the association between COVID-19 health literacy, trust in the
    pandemic response, and mental distress, during the COVID-19 pandemic in Ireland:
    a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    PubMed: https://www.amedeo.com/p2.php?id=37997063&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37997063
  63. QuickStats: Age-Adjusted Percentage* of Adults Aged >/=18 Years Who Received an
    Influenza Vaccination During the Past 12 Months,(dagger) by Sex and Race and
    Ethnicity( section sign) – National Health Interview Survey, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1313.
    PubMed: https://www.amedeo.com/p2.php?id=38032840&s=flu&pm=2
     
    Share: https://m.amedeo.com/38032840
  64. IOANNIDIS JPA, Zonta F, Levitt M.
    Variability in excess deaths across countries with different vulnerability during
    2020-2023.
    Proc Natl Acad Sci U S A. 2023;120:e2309557120.
    PubMed: https://www.amedeo.com/p2.php?id=38019858&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38019858
  65. TURNER CA, Khalil H, Murphy-Weinberg V, Hagenauer MH, et al.
    The impact of COVID-19 on a college freshman sample reveals genetic and
    nongenetic forms of susceptibility and resilience to stress.
    Proc Natl Acad Sci U S A. 2023;120:e2305779120.
    PubMed: https://www.amedeo.com/p2.php?id=38011555&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38011555
  66. TORCHE F, Nobles J.
    Vaccination, immunity, and the changing impact of COVID-19 on infant health.
    Proc Natl Acad Sci U S A. 2023;120:e2311573120.
    PubMed: https://www.amedeo.com/p2.php?id=38011548&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38011548
  67. CHENG CW, Wu CY, Wang SW, Chen JY, et al.
    Low-sugar universal mRNA vaccine against coronavirus variants with deletion of
    glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).
    Proc Natl Acad Sci U S A. 2023;120:e2314392120.
    PubMed: https://www.amedeo.com/p2.php?id=38011546&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38011546
  68. CONDOR CAPCHA JM, Kamiar A, Robleto E, Saad AG, et al.
    Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates
    cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
    Proc Natl Acad Sci U S A. 2023;120:e2308342120.
    PubMed: https://www.amedeo.com/p2.php?id=37983492&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37983492
  69. PAYNE AB, Ciesla AA, Rowley EAK, Weber ZA, et al.
    Impact of accounting for correlation between COVID-19 and influenza vaccination
    in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
    Vaccine. 2023 Nov 23:S0264-410X(23)01337-3. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=38000964&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/38000964
  70. HERZIG VAN WEES S, Stalgren M, Viberg N, Puranen B, et al.
    ā€œWho is Anders Tegnell?ā€ Unanswered questions hamper COVID-19 vaccine uptake: A
    qualitative study among ethnic minorities in Sweden.
    Vaccine. 2023 Nov 10:S0264-410X(23)01328-2. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37953100&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37953100
  71. BRUXVOORT KJ, Sy LS, Hong V, Lewin B, et al.
    Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US
    health care system.
    Vaccine. 2023 Nov 10:S0264-410X(23)01324-5. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37953096&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37953096
  72. DUDLEY MZ, Schwartz B, Brewer J, Kan L, et al.
    COVID-19 vaccination attitudes, values, intentions: US parents for their
    children, September 2021.
    Vaccine. 2023 Nov 9:S0264-410X(23)01295-1. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37951793&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37951793
  73. ANDERSON EC, Blair PS, Finn A, Ingram J, et al.
    Maternal vaccination provision in NHS maternity trusts across England.
    Vaccine. 2023 Nov 9:S0264-410X(23)01284-7. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37951792&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37951792
  74. YANG C, Zheng Z, Zheng P, Chen J, et al.
    Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for
    both pregnant women and neonates.
    Vaccine. 2023 Nov 8:S0264-410X(23)01322-1. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37949755&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37949755
  75. INOUE Y, Li Y, Yamamoto S, Fukunaga A, et al.
    The association between antipyretic analgesics use and SARS-CoV-2 antibody titers
    following the second dose of the BNT162b2 mRNA vaccine: An observational study.
    Vaccine. 2023 Nov 7:S0264-410X(23)01220-3. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37945490&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37945490
  76. HANSEN LG, Larsen LE, Rasmussen TB, Miar Y, et al.
    Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian
    farmed mink.
    Vaccine. 2023 Nov 4:S0264-410X(23)01288-4. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37932134&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37932134
  77. JONES G, Perry M, Bailey R, Arumugam S, et al.
    Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A
    multivariable linked data population analysis.
    Vaccine. 2023 Nov 4:S0264-410X(23)01279-3. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37932133&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37932133
  78. HONDA-OKUBO Y, Bowen R, Barker M, Bielefeldt-Ohmann H, et al.
    Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike
    protein vaccine protects hamsters against heterologous infection with Beta or
    Delta variants.
    Vaccine. 2023 Oct 18:S0264-410X(23)01190-8. doi: 10.1016/j.vaccine.2023.
    PubMed: https://www.amedeo.com/p2.php?id=37863669&s=flu&pm=2
    ABSTRACT available
    Share: https://m.amedeo.com/37863669
  79. PREVOT AA, Wisner EL.
    Influenza Vaccine Effectiveness Among Children: 2011-2020.
    Pediatrics. 2023;152.
    PubMed: https://www.amedeo.com/p2.php?id=38038578&s=flu&pm=2
     
    Share: https://m.amedeo.com/38038578

https://etidioh.wordpress.com/2023/12/02/influenza-and-covid19-research-references-by-amedeo-december-2nd-2023/

#avianInfluenza #ayurvedic #coronavirus #COVID19 #fluSeason #fluSeason #health #influenza #research #seasonalInfluenza #texturedCable

Sifasevensifaseven
2023-10-07

The Energy of Five Elements. In Healing, there are five elements. All work in harmony, but what are they?

sifasevenwriting.wordpress.com

2023-10-04

I've been trying to eat a little healthier lately and also back away from wheat. I've been testing out new vegetarian and ayurvedic recipes. This rice may be one of my favorite (and easy) side dishes. Caveat- it didn't need to cook 20 minutes.

joyfulbelly.com/Ayurveda/recip

#ayurvedic #recipes

Matt WillemsenNonog@fedibird.com
2023-09-17

Hidden Danger in Herbal Remedies – How Ayurvedic Medicine Can Cause Lead Poisoning
A young woman developed lead toxicity after consuming Ayurvedic medicines for over a year, initially presenting with nonspecific symptoms like abdominal pain and anemia. After her diagnosis, investigations led to the seizure of hundreds of pills with high lead levels from an Ayurvedic clinic, prompting public advisories from health authorities.
scitechdaily.com/hidden-danger
#lead #poisoning #traditional or #herbal #Ā­medications #ayurvedic

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst